Journals in Toxicology

1-10 of 44 results in All results

African Journal of Urology

ISSN: 1110-5704

As of 1 January 2019 the journal has been transferred to the new Publisher, Springer Nature.

Aquatic Toxicology

ISSN: 0166-445X
5 Year impact factor: 5.2
Impact factor: 4.5

Aquatic Toxicology publishes significant contributions that increase the understanding of the impact of harmful substances (including natural and synthetic chemicals) on aquatic organisms and ecosystems. Aquatic Toxicology considers both laboratory and field studies with a focus on marine/ freshwater environments. The journal strives to attract high quality original scientific papers, critical reviews and expert opinion papers in the following areas: • Effects of harmful substances on molecular, cellular, sub-organismal, organismal, population, community, and ecosystem level; • Toxic mechanisms; • Genetic disturbances, transgenerational effects, behavioral and adaptive responses; • Impacts of harmful substances on structure, function of and services provided by aquatic ecosystems; • Mixture toxicity assessment; • Statistical approaches to predict exposure to and hazards of contaminants The journal also considers manuscripts in other areas, such as the development of innovative concepts, approaches, and methodologies, which promote the wider application of toxicological datasets to the protection of aquatic environments and inform ecological risk assessments and decision making by relevant authorities. Aquatic Toxicology does not publish articles that focus on the health of aquaculture organisms associated with aquaculture practices, unless these studies enhance our understanding of the potential effects of chemical stressors associated with aquaculture (e.g. pesticides use, water quality degradation) on aquatic organisms and/or ecosystems. Aquatic Toxicology does not consider articles that focus on monitoring the presence of chemicals in the environment unless these studies further investigate the impacts of the chemicals on aquatic organisms and/or ecological systems. Furthermore, studies that characterize the potential risks of contaminated fish or other aquatic food products on humans or livestock are outside of the scope of the journal.

Cancer Letters

ISSN: 0304-3835
5 Year impact factor: 8.9
Impact factor: 9.7

An international journal providing a forum for original and pertinent contributions in cancer research Cancer Letters is an international journal that considers full-length articles and Mini Reviews in the broad area of basic and translational oncology. Additionally, Special Issues highlight topical areas in cancer research. Basic areas of interest to a broad readership of Cancer Letters include the molecular genetics and cell biology of cancer, radiation biology, molecular pathology, hormones and cancer, viral oncology, metastasis, and chemoprevention. The journal places emphasis on experimental therapeutics, particularly targeted therapies for personalized cancer medicine, including metronomic chemotherapy. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services. Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: https://service.elsevier.com.

Chemico-Biological Interactions

ISSN: 0009-2797
5 Year impact factor: 4.9
Impact factor: 5.1

A journal of molecular, cellular and biochemical toxicology Chemico-Biological Interactions publishes research reports and review articles that examine the molecular, cellular, and/or biochemical basis of toxicologically relevant outcomes. Special emphasis is placed on toxicological mechanisms associated with interactions between chemicals and biological systems. Outcomes may include all traditional endpoints caused by synthetic or naturally occurring chemicals, both in vivo and in vitro. Endpoints of interest include, but are not limited to carcinogenesis, mutagenesis, respiratory toxicology, neurotoxicology, reproductive and developmental toxicology, and immunotoxicology.CBI discourages papers that are descriptive in nature and that do not address toxicological mechanisms (e.g., reports of toxicological effects following chemical exposure in absence of mechanistic experiments). CBI also discourages papers reporting on toxicological effects from materials, such as plant extracts or herbal medicines, that have not been chemically characterized.Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center

Comparative Biochemistry and Physiology - Part C: Toxicology & Pharmacology

ISSN: 1532-0456
5 Year impact factor: 3.8
Impact factor: 3.9

Comparative Biochemistry & Physiology (CBP) publishes papers in comparative, environmental and evolutionary physiology. Part C: Toxicology and Pharmacology (CBPC), focuses on toxicological mechanisms at different levels of organization, primarily chemical and drug action, biotransformation of xenobiotics, endocrine disruptors, nanoparticles, pharmaceuticals, and natural products chemistry. Most studies employ a molecular approach in combination with observations of higher levels of organization to assess the mechanism by which xenobiotics affect physiology. Analytical verification of exposure concentrations is strongly recommended for manuscripts reporting toxicological studies. All four CBP journals support and follow the editorial direction from all the major societies in the field: Australia & New Zealand Society of Comparative Physiology and Biochemistry (ANZSCPB) American Physiological Society (APS) Canadian Society of Zoologists (CSZ) Deutsche Zoologische Gesellschaft (DZG) European Society of Comparative Physiology and Biochemistry (ESCPB) Japanese Society for Comparative Physiology and Biochemistry (JSCPB) South American Society for Comparative Physiology and Biochemistry (SASCPB) Societe de Physiologie (SDP) Society for Experimental Biology (SEB) Society for Integrative & Comparative Biology (SICB) Benefits to authors CBP journals are focused on promoting the authors and the work published in the journal: All articles are carefully evaluated directly by the Editors-in-Chief who are leading experts in their field. Availability: contact the Editor-in-Chief for any questions you may have. The Journal will provide upon request free PDFs to all authors who may not have access to their articles via their institution or library. Publication is free to authors (no color or page charges). Supporting open access: if your funding body or institution requires your article to be open access, CBP offers that option. Please see details here. Reuse figures from any CBP article via "get rights and content" hyperlink available within each article (below author names and affiliations) on ScienceDirect. Please click here for more information on more general author services. Other CBP journals Part A (CBPA): Molecular & Integrative Physiology Part B (CBPB): Biochemistry & Molecular Biology Part D (CBPD): Genomics & Proteomics

Comparative Biochemistry and Physiology - Part C: Toxicology & Pharmacology

Computational Toxicology

ISSN: 2468-1113

Computational Toxicology is an international journal publishing computational approaches that assist in the toxicological evaluation of new and existing chemical substances assisting in their safety assessment. Scope: All effects relating to human health and environmental toxicity and fate Prediction of toxicity, metabolism, fate and physico-chemical properties The development of models from read-across, (Q)SARs, PBPK, QIVIVE, Multi-Scale Models Big Data in toxicology: integration, management, analysis Implementation of models through AOPs, IATA, TTC Regulatory acceptance of models: evaluation, verification and validation From metals, to small organic molecules to nanoparticles Pharmaceuticals, pesticides, foods, cosmetics, fine chemicals Bringing together the views of industry, regulators, academia, NGOs

Current Opinion in Toxicology

ISSN: 2468-2020
Impact factor: 4.6

Affiliated with the International Union of Toxicology Current Opinion in Toxicology aims to stimulate scientifically grounded, interdisciplinary, multi-scale debate and exchange of ideas. It contains polished, concise, and timely reviews and opinions, with particular emphasis on those articles published in the past two years. In addition to describing recent trends, the authors are encouraged to give their subjective opinion of the topics discussed. In Current Opinion in Toxicology we help the reader by providing in a systematic manner: 1. The views of experts on current advances in their field in a clear and readable form. 2. Evaluations of the most interesting papers, annotated by experts, from the great wealth of original publications. Current Opinion in Toxicology will serve as an invaluable source of information for researchers, lecturers, teachers, professionals, policy makers and students. Current Opinion in Toxicology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. It is a companion to the new Gold Open Access journal Current Research in Toxicology and is part of the Current Opinion and Research(CO+RE) suite of journals. All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow. Division of the subject into sections: For this purpose, the scope of Toxicology is divided into six selected, high impact themed sections, each of which is reviewed once a year: Mechanistic Toxicology Metabolic Toxicology Risk assessment in Toxicology Genomic Toxicology Systems Toxicology Translational Toxicology Expertise: Expert authors, who are leaders in their field, are invited to write short review articles in which they present recent developments in their subject and provide short annotations to the papers that they think are most relevant. Comprehensiveness: There are 27 high-impact Current Opinion review journals in a range of subjects from food science to green and sustainable chemistry. Impact: In addition to a vast readership, Current Opinion titles enjoy high citations, Impact Factors, and CiteScores. Discoverability: Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast, global audience. Selection of topics to be reviewed Section Editors, who are major authorities in the field, are appointed by the Editors in Chief of the journal. They divide their sections into a number of topics, ensuring that the field is comprehensively covered and that all issues of current importance are emphasised. Section Editors commission reviews from authors on each topic that they have selected and arrange for the peer review process. The papers are reviewed by 2 independent reviewers. Reviews Authors write short review articles (approx. 2500 words), in which they present recent developments in their subject, emphasising the aspects that, in their opinion, are most important. In addition, they provide short annotations to the papers that they consider to be most interesting from all those published in their topic over the 3-5 years. All content published in Current Opinion in Toxicology is by invitation only. Editorial Overview Section Editors write a short overview at the beginning of the section, to introduce the reviews and to draw the reader's attention to any particularly interesting developments. Ethics in Publishing: General Statement The Editors and the Publisher of this journal believe that there are fundamental principles underlying scholarly and professional publishing. While this may not amount to a formal 'code of conduct', these fundamental principles with respect to the authors' paper, are that the paper should: i) be the authors' own original work, which has not been previously published elsewhere, ii) reflect the authors' own research and analysis and do so in a truthful and complete manner, iii) properly credit the meaningful contributions of co-authors and co-researchers, iv) not be submitted to more than one journal for consideration, and v) be appropriately placed in the context of prior and existing research. Of equal importance are ethical guidelines dealing with research methods and research funding, including issues dealing with informed consent, research subject privacy rights, conflicts of interest, and sources of funding. While it may not be possible to draft a 'code' that applies adequately to all instances and circumstances, we believe it useful to outline our expectations of authors and procedures that the journal will employ in the event of questions concerning author conduct. With respect to conflicts of interest, the Publisher now requires authors to declare any conflicts of interest that relate to papers accepted for publication in this journal. A conflict of interest may exist when an author or the author's institution has a financial or other relationship with other people or organizations that may inappropriately influence the author's work. A conflict can be actual or potential and full disclosure to the journal is the safest course. All submissions to the journal must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest. The journal may use such information as a basis for editorial decisions and may publish such disclosures, if they are believed to be important to readers in judging the manuscript. A decision may be made by the journal not to publish on the basis of the declared conflict. For more information, please refer to: https://www.elsevier.com/conflictsofinterest The CiteScore for this journal is 9.1 and it ranks 8th in Scopus Toxicology category.

Current Research in Toxicology

ISSN: 2666-027X
5 Year impact factor: 3.3
Impact factor: 3.3

Current Research in Toxicology (CRTOX) is a new primary research, gold open access journal from Elsevier. CRTOX publishes original research on the broad range of toxicology subfields and drawing from various, overlapping disciplines, with particular attention to the aspects of linking mechanistic toxicity data to apical effects, addressing vulnerable populations and life stages, systems toxicology and computational models, and synthetic biology and other innovative technologies. Current Research in Toxicology is a peer-reviewed gold open access (OA) journal and upon acceptance all articles are permanently and freely available. It is a companion to the highly regarded review journal Current Opinion in Toxicology (2018 Citescore 2.27) and is part of the Current Opinion and Research(CO+RE) suite of journals . All CO+RE journals leverage the Current Opinion legacy-of editorial excellence, high-impact, and global reach-to ensure they are a widely read resource that is integral to scientists' workflow. Current Research in Toxicology publishes original research on the broad range of toxicology subfields and drawing from various, overlapping disciplines, with particular attention to the aspects of: 1. Linking mechanistic toxicity data to apical effects. 2. Addressing vulnerable populations and life stages. 3. Systems toxicology and Computational models. 4. Synthetic biology and other Innovative technologies. Current Research in Toxicology builds on Elsevier's reputation for excellence in scientific publishing and long-standing commitment to communicating reproducible biomedical research targeted at improving human health. Expertise - Editors and Editorial Board bring depth and breadth of expertise and experience to the journal. Speed - Submission and peer review is fast, and publication of final manuscripts is instantaneous. Discoverability - Articles get high visibility and maximum exposure on an industry-leading platform that reaches a vast global audience. Ethics in Publishing: General Statement The Editor(s) and Publisher of this Journal believe that there are fundamental principles underlying scholarly or professional publishing. For more information, please refer to: https://www.elsevier.com/conflictsofinterest

Emerging Trends in Drugs, Addictions, and Health

ISSN: 2667-1182

INTERNATIONAL SOCIETY FOR THE STUDY OF EMERGING DRUGS (ISSED) Emerging Trends in Drugs, Addictions, and Health is a new international Journal devoted to the rapid publication of authoritative papers on Novel Psychoactive Substances (NPS), Addictions and associated health phenomena. The Journal has a multidisciplinary nature and aims to bring together studies which are relevant for heterogeneous authors and readers. Manuscripts related to pharmacology, clinical practice, doping science, mental health, public health, forensic medicine, experimental psychology, genetics, molecular biology, internal medicine, neuroscience, health psychology, health policy, health economics, and treatment trials are encouraged for submission as far as they deal with the ever changing world of addictions and psychoactive substances. The overall purpose of the Journal is to contribute to improve the knowledge on the field with a comprehensive biological, psychological, and social perspective.

Environmental Toxicology and Pharmacology

ISSN: 1382-6689
5 Year impact factor: 4.8
Impact factor: 4.3

Environmental Toxicology and Pharmacology publishes the results of studies concerning toxic and pharmacological effects of (human and veterinary) drugs and of environmental contaminants in animals and man.Areas of special interest are: molecular mechanisms of toxicity, biotransformation and toxicokinetics (including toxicokinetic modelling), molecular, biochemical and physiological mechanisms explaining differences in sensitivity between species and individuals, the characterisation of pathophysiological models and mechanisms involved in the development of effects and the identification of biological markers that can be used to study exposure and effects in man and animals. In addition to full length papers, short communications, full-length reviews and mini-reviews, Environmental Toxicology and Pharmacology will publish in depth assessments of special problem areas. The latter publications may exceed the length of a full length paper three to fourfold. A basic requirement is that the assessments are made under the auspices of international groups of leading experts in the fields concerned. The information examined may either consist of data that were already published, or of new data that were obtained within the framework of collaborative research programmes. Provision is also made for the acceptance of minireviews on (classes of) compounds, toxicities or mechanisms, debating recent advances in rapidly developing fields that fall within the scope of the journal. Benefits to authors We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services . Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our Support Center